Wiersinga WM - Search Results

1

Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments.

Terwee CB, Dekker FW, Mourits MP, Gerding MN, Baldeschi L, Kalmann R, Prummel MF, Wiersinga WM. Terwee CB, et al. Among authors: wiersinga wm. Clin Endocrinol (Oxf). 2001 Mar;54(3):391-8. doi: 10.1046/j.1365-2265.2001.01241.x. Clin Endocrinol (Oxf). 2001. PMID: 11298093

2

Orbital decompression for Graves' ophthalmopathy by inferomedial, by inferomedial plus lateral, and by coronal approach.

Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R. Mourits MP, et al. Among authors: wiersinga wm. Ophthalmology. 1990 May;97(5):636-41. doi: 10.1016/s0161-6420(90)32532-0. Ophthalmology. 1990. PMID: 2342809

3

Medical management of Graves' ophthalmopathy.

Prummel MF, Wiersinga WM. Prummel MF, et al. Among authors: wiersinga wm. Thyroid. 1995 Jun;5(3):231-4. doi: 10.1089/thy.1995.5.231. Thyroid. 1995. PMID: 7580273 Review.

4

Measuring eye movements in Graves ophthalmopathy.

Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Mourits MP, et al. Among authors: wiersinga wm. Ophthalmology. 1994 Aug;101(8):1341-6. doi: 10.1016/s0161-6420(94)31164-x. Ophthalmology. 1994. PMID: 8058278

5

Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy.

Prummel MF, Mourits MP, Blank L, Berghout A, Koornneef L, Wiersinga WM. Prummel MF, et al. Among authors: wiersinga wm. Lancet. 1993 Oct 16;342(8877):949-54. doi: 10.1016/0140-6736(93)92001-a. Lancet. 1993. PMID: 8105213 Clinical Trial.

6

Smoking and risk of Graves' disease.

Prummel MF, Wiersinga WM. Prummel MF, et al. Among authors: wiersinga wm. JAMA. 1993 Jan 27;269(4):479-82. JAMA. 1993. PMID: 8419666

7

A new ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves ophthalmopathy.

Prummel MF, Suttorp-Schulten MS, Wiersinga WM, Verbeek AM, Mourits MP, Koornneef L. Prummel MF, et al. Among authors: wiersinga wm. Ophthalmology. 1993 Apr;100(4):556-61. doi: 10.1016/s0161-6420(93)31607-6. Ophthalmology. 1993. PMID: 8479715 Clinical Trial.

8

Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.

Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Mourits MP, et al. Among authors: wiersinga wm. Clin Endocrinol (Oxf). 1997 Jul;47(1):9-14. doi: 10.1046/j.1365-2265.1997.2331047.x. Clin Endocrinol (Oxf). 1997. PMID: 9302365 Clinical Trial.

9

Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument.

Gerding MN, Terwee CB, Dekker FW, Koornneef L, Prummel MF, Wiersinga WM. Gerding MN, et al. Among authors: wiersinga wm. Thyroid. 1997 Dec;7(6):885-9. doi: 10.1089/thy.1997.7.885. Thyroid. 1997. PMID: 9459632

10

Immunomodulatory treatment of Graves' ophthalmopathy.

Prummel MF, Wiersinga WM. Prummel MF, et al. Among authors: wiersinga wm. Thyroid. 1998 Jun;8(6):545-8. doi: 10.1089/thy.1998.8.545. Thyroid. 1998. PMID: 9669295 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters